Comparison of lepirudin-treated patients and historical control group.

Cumulative incidence of events (new TEC, limb amputation, and death) was higher in the historical control group (scattered line) than in the lepirudin group (solid line); P = .004. The number of patients at risk is given at the top of the figure.